A Mutation in the Ovine Cathepsin D Gene Causes a Congenital Lysosomal Storage Disease with Profound Neurodegeneration

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2000 Jun 17

PMID 10856224

Citations 71

Authors

J Tyynela

I Sohar

D E Sleat

R M Gin

R J Donnelly

M Baumann

M Haltia

P Lobel

Affiliations

Soon will be listed here.

Abstract

The neuronal ceroid lipofuscinoses (NCLs) constitute a group of neurodegenerative storage diseases characterized by progressive psychomotor retardation, blindness and premature death. Pathologically, there is accumulation of autofluorescent material in lysosome-derived organelles in a variety of cell types, but neurons in the central nervous system appear to be selectively affected and undergo progressive death. In this report we show that a novel form of NCL, congenital ovine NCL, is caused by a deficiency in the lysosomal aspartyl proteinase cathepsin D. A single nucleotide mutation in the cathepsin D gene results in conversion of an active site aspartate to asparagine, leading to production of an enzymatically inactive but stable protein. This results in severe cerebrocortical atrophy and early death, providing strong evidence for an important role of cathepsin D in neuronal development and/or homeostasis.

Citing Articles

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.

Terron H, Parikh S, Abdul-Hay S, Sahara T, Kang D, Dickson D Alzheimers Res Ther. 2024; 16(1):70.

PMID: 38575959 PMC: 10996108. DOI: 10.1186/s13195-024-01443-6.

Aberrant Autophagy Impacts Growth and Multicellular Development in a Knockout Model of CLN5 Disease.

McLaren M, Mathavarajah S, Kim W, Yap S, Huber R Front Cell Dev Biol. 2021; 9:657406.

PMID: 34291044 PMC: 8287835. DOI: 10.3389/fcell.2021.657406.

Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease.

Suire C, Leissring M J Exp Neurol. 2021; 2(1):10-15.

PMID: 33665647 PMC: 7929084.

Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Rosenberg J, Chen A, Kaminsky S, Crystal R, Sondhi D Expert Opin Orphan Drugs. 2020; 7(11):473-500.

PMID: 33365208 PMC: 7755158. DOI: 10.1080/21678707.2019.1684258.

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40.

Suire C, Abdul-Hay S, Sahara T, Kang D, Brizuela M, Saftig P Alzheimers Res Ther. 2020; 12(1):80.

PMID: 32631408 PMC: 7339583. DOI: 10.1186/s13195-020-00649-8.

References

Vassar R, Bennett B, Kahn S, Mendiaz E, Denis P, Teplow D . Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999; 286(5440):735-41. DOI: 10.1126/science.286.5440.735. View

Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H . Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 1995; 14(15):3599-608. PMC: 394433. DOI: 10.1002/j.1460-2075.1995.tb00029.x. View

Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Forstl H, Maier W . A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol. 2000; 47(3):399-403. View

Haltia M, Rapola J, Santavuori P, Keranen A . Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies. J Neurol Sci. 1973; 18(3):269-85. DOI: 10.1016/0022-510x(73)90076-2. View

Barrett A, KIRSCHKE H . Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 1981; 80 Pt C:535-61. DOI: 10.1016/s0076-6879(81)80043-2. View

Gieselmann V, Hasilik A, von Figura K . Processing of human cathepsin D in lysosomes in vitro. J Biol Chem. 1985; 260(5):3215-20. View

Garborg I, TORVIK A, Hals J, Tangsrud S, Lindemann R . Congenital neuronal ceroid lipofuscinosis. A case report. Acta Pathol Microbiol Immunol Scand A. 1987; 95(3):119-25. DOI: 10.1111/j.1699-0463.1987.tb00017_95a.x. View

. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell. 1995; 82(6):949-57. DOI: 10.1016/0092-8674(95)90274-0. View

Verkruyse L, Hofmann S . Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem. 1996; 271(26):15831-6. DOI: 10.1074/jbc.271.26.15831. View

10.

Sleat D, Sohar I, Lackland H, Majercak J, Lobel P . Rat brain contains high levels of mannose-6-phosphorylated glycoproteins including lysosomal enzymes and palmitoyl-protein thioesterase, an enzyme implicated in infantile neuronal lipofuscinosis. J Biol Chem. 1996; 271(32):19191-8. DOI: 10.1074/jbc.271.32.19191. View

11.

Lane S, Jolly R, Schmechel D, Alroy J, Boustany R . Apoptosis as the mechanism of neurodegeneration in Batten's disease. J Neurochem. 1996; 67(2):677-83. DOI: 10.1046/j.1471-4159.1996.67020677.x. View

12.

Prasad V, Pullarkat R . Brain lysosomal hydrolases in neuronal ceroid-lipofuscinoses. Mol Chem Neuropathol. 1996; 29(2-3):169-79. DOI: 10.1007/BF02815000. View

13.

Sleat D, Donnelly R, Lackland H, Liu C, Sohar I, Pullarkat R . Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997; 277(5333):1802-5. DOI: 10.1126/science.277.5333.1802. View

14.

Jarvela I, Sainio M, Rantamaki T, Olkkonen V, Carpen O, Peltonen L . Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet. 1998; 7(1):85-90. DOI: 10.1093/hmg/7.1.85. View

15.

Xie S, Green J, Bixby J, Szafranska B, DeMartini J, Hecht S . The diversity and evolutionary relationships of the pregnancy-associated glycoproteins, an aspartic proteinase subfamily consisting of many trophoblast-expressed genes. Proc Natl Acad Sci U S A. 1997; 94(24):12809-16. PMC: 24220. DOI: 10.1073/pnas.94.24.12809. View

16.

Goebel H, Sharp J . The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol. 1998; 8(1):151-62. PMC: 8098143. DOI: 10.1111/j.1750-3639.1998.tb00142.x. View

17.

Sohar I, Sleat D, Gong Liu C, Ludwig T, Lobel P . Mouse mutants lacking the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor are impaired in lysosomal enzyme transport: comparison of cation-independent and cation-dependent mannose 6-phosphate receptor-deficient mice. Biochem J. 1998; 330 ( Pt 2):903-8. PMC: 1219223. DOI: 10.1042/bj3300903. View

18.

Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander E, Peltonen L . CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet. 1998; 19(3):286-8. DOI: 10.1038/975. View

19.

Vetvicka V, Vetvickova J, Fusek M . Effect of procathepsin D and its activation peptide on prostate cancer cells. Cancer Lett. 1998; 129(1):55-9. DOI: 10.1016/s0304-3835(98)00091-3. View

20.

Sleat D, Sohar I, Pullarkat P, Lobel P, Pullarkat R . Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses. Biochem J. 1998; 334 ( Pt 3):547-51. PMC: 1219721. DOI: 10.1042/bj3340547. View